Paper29372017
Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes.
García-Manrique P and 4 others. J Extracell Vesicles, 2018. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes. Papers, record 29372017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29372017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26725829 | Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. | J Extracell Vesicles | 2015 | https://conductscience.org/library/papers/26725829 | PubMed |
| 2 | 23344721 | miR-1289 and "Zipcode"-like Sequence Enrich mRNAs in Microvesicles. | Mol Ther Nucleic Acids | 2012 | https://conductscience.org/library/papers/23344721 | PubMed |
| 3 | 22785357 | Comparison of methods for isolating exosomes from bovine milk. | J Vet Med Sci | 2012 | https://conductscience.org/library/papers/22785357 | PubMed |
| 4 | 25940789 | Exosome isolation: a microfluidic road-map. | Lab Chip | 2015 | https://conductscience.org/library/papers/25940789 | PubMed |
| 5 | 12517782 | Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. | Cancer Res | 2003 | https://conductscience.org/library/papers/12517782 | PubMed |
| 6 | 23111789 | Microfluidic filtration system to isolate extracellular vesicles from blood. | Lab Chip | 2012 | https://conductscience.org/library/papers/23111789 | PubMed |
| 7 | 16275099 | Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. | Mol Ther | 2006 | https://conductscience.org/library/papers/16275099 | PubMed |
| 8 | 25220352 | Surface functionalization of exosomes using click chemistry. | Bioconjug Chem | 2014 | https://conductscience.org/library/papers/25220352 | PubMed |
| 9 | 15236448 | Current methods for attaching targeting ligands to liposomes and nanoparticles. | J Pharm Sci | 2004 | https://conductscience.org/library/papers/15236448 | PubMed |
| 10 | 25819214 | Ready-made chromatography columns for extracellular vesicle isolation from plasma. | J Extracell Vesicles | 2015 | https://conductscience.org/library/papers/25819214 | PubMed |
| 11 | 25132601 | Nanovesicles engineered from ES cells for enhanced cell proliferation. | Biomaterials | 2014 | https://conductscience.org/library/papers/25132601 | PubMed |
| 12 | 24223258 | Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma. | J Extracell Vesicles | 2013 | https://conductscience.org/library/papers/24223258 | PubMed |
| 13 | 23933616 | Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications. | Adv Drug Deliv Rev | 2013 | https://conductscience.org/library/papers/23933616 | PubMed |
| 14 | 25849885 | Low pH increases the yield of exosome isolation. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/25849885 | PubMed |
| 15 | 24957510 | Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. | Tissue Eng Part B Rev | 2015 | https://conductscience.org/library/papers/24957510 | PubMed |
| 16 | 24493004 | Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. | Lab Chip | 2014 | https://conductscience.org/library/papers/24493004 | PubMed |
| 17 | 25836593 | Exosomes as drug delivery vehicles for Parkinson's disease therapy. | J Control Release | 2015 | https://conductscience.org/library/papers/25836593 | PubMed |
| 18 | 27235383 | Exosomal formulation enhances therapeutic response of celastrol against lung cancer. | Exp Mol Pathol | 2016 | https://conductscience.org/library/papers/27235383 | PubMed |
| 19 | 8496245 | Electroporation: a general phenomenon for manipulating cells and tissues. | J Cell Biochem | 1993 | https://conductscience.org/library/papers/8496245 | PubMed |
| 20 | 23894228 | FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver. | Pharmaceuticals (Basel) | 2013 | https://conductscience.org/library/papers/23894228 | PubMed |
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42548936 | Tissue regeneration strategies based on mesenchymal stem cell-derived extracellular vesicles: from bench to bedside. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42548936 | PubMed |
| 42277017 | Stem cell-derived extracellular vesicles and artificial nanovesicles: a translational framework for cell-free wound repair. | NPJ Regen Med | 2026 | https://conductscience.org/library/papers/42277017 | PubMed |
| 42053700 | Therapeutic Mechanisms of Stem Cell-Derived Exosomes for Neurological Disorders: An Overview. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42053700 | PubMed |
| 41827839 | ABA-Induced Cargo Proteins Loading in Extracellular Vesicles for Gene Editing. | Cells | 2026 | https://conductscience.org/library/papers/41827839 | PubMed |
| 41809263 | Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress. | Asian J Pharm Sci | 2025 | https://conductscience.org/library/papers/41809263 | PubMed |
| 41392147 | Advances in extracellular vesicle-based nanomedicine for regenerative orthopaedics. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41392147 | PubMed |
| 41356731 | Nanoparticles: a new frontier in neurodegenerative disease therapy. | Front Med Technol | 2025 | https://conductscience.org/library/papers/41356731 | PubMed |
| 40969663 | The New Approach to Treating Erectile Dysfunction: Stem Cell-Derived Extracellular Vesicles. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40969663 | PubMed |
| 40768606 | Advances in the extracellular vesicles treatment of alopecia. | Ann Med | 2025 | https://conductscience.org/library/papers/40768606 | PubMed |
| 40757165 | Extracellular vesicles and their mimetics: clinical application prospects in medical aesthetics. | Burns Trauma | 2025 | https://conductscience.org/library/papers/40757165 | PubMed |
| 40444049 | Tumor-derived exosomes as promising tools for cancer diagnosis and therapy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40444049 | PubMed |
| 40315797 | Extracellular vesicles as cancer biomarkers and drug delivery strategies in clinical settings: Advances, perspectives, and challenges. | Clinics (Sao Paulo) | 2025 | https://conductscience.org/library/papers/40315797 | PubMed |
| 39911262 | An Injectable Hydrogel Bioimplant Loaded with Engineered Exosomes and Triple Anti-Tuberculosis Drugs with Potential for Treating Bone and Joint Tuberculosis. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39911262 | PubMed |
| 39771472 | Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771472 | PubMed |
| 39698444 | New insights of engineering plant exosome-like nanovesicles as a nanoplatform for therapeutics and drug delivery. | Extracell Vesicles Circ Nucl Acids | 2022 | https://conductscience.org/library/papers/39698444 | PubMed |
| 39684236 | Glioma-Derived Exosomes and Their Application as Drug Nanoparticles. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684236 | PubMed |
| 39640047 | Engineering Strategies of Plant-Derived Exosome-Like Nanovesicles: Current Knowledge and Future Perspectives. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/39640047 | PubMed |
| 39634409 | Revolutionizing medicine: Harnessing plant-derived vesicles for therapy and drug transport. | Heliyon | 2024 | https://conductscience.org/library/papers/39634409 | PubMed |
| 39603560 | Extracellular vesicle therapeutics for cardiac repair. | J Mol Cell Cardiol | 2025 | https://conductscience.org/library/papers/39603560 | PubMed |
| 39591021 | Development and Biological Characterization of Cancer Biomimetic Membrane Nanovesicles for Enhancing Therapy Efficacy in Human Glioblastoma Cells. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/39591021 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29372017
GET https://conductscience.org/api/papers/v1/29372017/references?page=2